Cart
sales@molnova.com
Benin
CAS No. 22181-94-8
Benin( Butocin | Butocine )
Catalog No. M24003 CAS No. 22181-94-8
Benin is an effective cytostatic drug used for the treatment of generalized carcinoma of the breast.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 542 | In Stock |
|
| 5MG | 493 | In Stock |
|
| 10MG | 678 | In Stock |
|
| 25MG | 1007 | In Stock |
|
| 50MG | 1321 | In Stock |
|
| 100MG | 1776 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBenin
-
NoteResearch use only, not for human use.
-
Brief DescriptionBenin is an effective cytostatic drug used for the treatment of generalized carcinoma of the breast.
-
DescriptionBenin is an effective cytostatic drug used for the treatment of generalized carcinoma of the breast.(In Vitro):Benin is a cytostatic drug, but inactive in the standard plate incorporation method of Ames reversion test using four Salmonella typhimurium strains.
-
In Vitro——
-
In Vivo——
-
SynonymsButocin | Butocine
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number22181-94-8
-
Formula Weight337.4
-
Molecular FormulaC14H19N5O3S
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESCCOC(=O)CNC(=O)CCCCSC1=NC=NC2=C1NC=N2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.J. Marhan. Mutagenicity of cytostatic drugs in a bacterial system. Folia Microbiologica October 1995, Volume 40, Issue 5, pp 462-466.
molnova catalog
related products
-
CL2A-SN-38 DCA 127...
CL2A-SN-38 is a drug-linker conjugate composed of a potent a DNA Topoisomerase I inhibitor SN-38 and a linker CL2A to make antibody drug conjugate (ADC).
-
MM 54
Potent apelin receptor antagonist (Ki = 82 nM; IC50 = 93 nM). Antagonizes the inhibitory affect of [Pyr1]-Apelin-13 on forskolin-induced cAMP accumulation in CHO-K1-APJ cells. Recuces tumor expansion and lengthens survival time in a mouse xenograft model of glioblastoma.
-
Aminoadipic acid
Aminoadipic acid (2-aminoadipate) is a metabolite in the principal biochemical pathway of lysine. It is an intermediate in the metabolism of lysine and saccharopine. It antagonizes neuroexcitatory activity modulated by the glutamate receptor N-methyl-D-aspartate (NMDA).
